Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Change in the regulatory framework for zolpidem: What is the impact on the landscape of the prescription of sedative medications? The French national ZORRO study
Marion Istvan, Pascal Caillet, Morgane Rousselet, et al.
British Journal of Clinical Pharmacology (2021) Vol. 87, Iss. 8, pp. 3310-3319
Open Access | Times Cited: 19

Showing 19 citing articles:

Long-term use of benzodiazepines in chronic insomnia: a European perspective
Michael Soyka, Imane Wild, Bérangère Caulet, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 33
Inputs of pharmacoepidemiology in addictovigilance: how do they fit together?
Thomas Soeiro, Amélie Daveluy, Caroline Victorri‐Vigneau, et al.
Therapies (2024)
Open Access | Times Cited: 4
Systematic assessment of non‐medical use of prescription drugs using doctor‐shopping indicators: A nation‐wide, repeated cross‐sectional study
Thomas Soeiro, Vincent Pradel, Maryse Lapeyre‐Mestre, et al.
Addiction (2023) Vol. 118, Iss. 10, pp. 1984-1993
Open Access | Times Cited: 7
Unintended impact of pharmacovigilance regulatory interventions: A systematic review
Tomas Lasys, Yared Santa‐Ana‐Téllez, Satu J. Siiskonen, et al.
British Journal of Clinical Pharmacology (2023) Vol. 89, Iss. 12, pp. 3491-3502
Open Access | Times Cited: 6
Weighted blanket and sleep medication use among adults with psychiatric diagnosis – a population-based register study
Steinn Steingrímsson, Ellen Odéus, Mats Cederlund, et al.
Nordic Journal of Psychiatry (2021) Vol. 76, Iss. 1, pp. 29-36
Open Access | Times Cited: 14
French national addictovigilance follow-up of zolpidem between 2014 and 2020: evolution of drug abuse, misuse and dependence before and after the regulatory change
Aurélie Aquizerate, Edouard‐Jules Laforgue, Marion Istvan, et al.
European Journal of Public Health (2023) Vol. 33, Iss. 2, pp. 169-175
Open Access | Times Cited: 5
Use of State Sequence Analysis in Pharmacoepidemiology: A Tutorial
Jacopo Vanoli, Consuelo Rubina Nava, Chiara Airoldi, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 24, pp. 13398-13398
Open Access | Times Cited: 11
Prescribing Z-drugs in Greece: an analysis of the national prescription database from 2018 to 2021
Spyridon Siafis, Konstantinos Ν. Fountoulakis, Vasileios Fragkidis, et al.
BMC Psychiatry (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Nitrous oxide in France: Evolution of complications reported to the French monitoring system in the context of information from health authorities and regulatory measures
Marylène Guerlais, Aurélie Aquizerate, Amélie Daveluy, et al.
International Journal of Drug Policy (2023), pp. 104172-104172
Closed Access | Times Cited: 4
Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior
Edouard‐Jules Laforgue, Marion Istvan, Benoît Schreck, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 8, pp. 2176-2176
Open Access | Times Cited: 6
Did the pattern of use of zolpidem change since the enforcement of a new prescription rule? A latent class analysis using the French health insurance database
Marion Istvan, Morgane Rousselet, Edouard‐Jules Laforgue, et al.
Expert Opinion on Drug Safety (2022) Vol. 21, Iss. 9, pp. 1225-1234
Closed Access | Times Cited: 3
Evolution of the profiles of new psychotropic drug users before and during the COVID-19 crisis: an original longitudinal approach through multichannel sequence analysis using the French health-care database
Marion Istvan, Mélanie Duval, Karl Hodel, et al.
European Archives of Psychiatry and Clinical Neuroscience (2024)
Closed Access
The effect of education regarding treatment guidelines for schizophrenia and major depressive disorders on psychiatrists' hypnotic medication prescribing behavior: a multicenter study
Toshinori Nakamura, Ryuji Furihata, Naomi Hasegawa, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access
National impact of a constraining regulatory framework on pregabalin dispensations in France, 2020–2022
Julia de Ternay, Claire Meley, Patrick M. Guérin, et al.
International Journal of Drug Policy (2024) Vol. 135, pp. 104660-104660
Open Access
Case report: Additional grounds for tighter regulation? A case series of five women with zolpidem dependence from a Brazilian women-specific substance use disorder outpatient service
Gabriela Nunes Leal, Igor Studart, Caio Petrus Monteiro Figueiredo, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access
Zolpidem: A masked hero. A reply to ZORRO study
Fabio Lugoboni, Rebecca Casari, Francesca Fusina, et al.
British Journal of Clinical Pharmacology (2021) Vol. 87, Iss. 10, pp. 4040-4041
Open Access | Times Cited: 1
Did the New French Regulation of Zolpidem Decrease the Problematic Consumption of Zolpidem? A Field Study among Users
Edouard‐Jules Laforgue, Morgane Rousselet, Antoine Claudon, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 15, pp. 8920-8920
Open Access
Zolpidem: a masked hero. A reply to ZORRO study
Fabio Lugoboni, Rebecca Casari, Francesca Fusina, et al.
Authorea (Authorea) (2021)
Open Access
ZORRO: When the mask falls off—Comment
Marion Istvan, Edouard‐Jules Laforgue, Marylène Guerlais, et al.
British Journal of Clinical Pharmacology (2021) Vol. 88, Iss. 5, pp. 2450-2451
Open Access
Page 1

Scroll to top